Active compounds of licorice ameliorate microplastics-induced intestinal damage by targeting FADD

Wen Xue1, Xiuhe Fan1, Yujing Hui1

  • 1Co-construction Collaborative Innovation Center for Chinese Medicine Resources Industrialization by Shaanxi & Education Ministry/State Key Laboratory of Research & Development of Characteristic Qin Medicine Resources (Cultivation)/Shaanxi Innovative Drug Research Center, Shaanxi University of Chinese Medicine, Xianyang, 712046, China.

Insights

Licorice compounds protect rats from microplastic (MP) injury by reducing inflammation and improving organ function. These effects are linked to down-regulating and interacting with the FADD protein.

Area of Science:

  • Environmental Science
  • Toxicology
  • Pharmacology

Background:

  • Microplastics (MPs) are emerging environmental pollutants with potential human health risks.
  • The impact of MPs on internal organs like the colon and liver requires further investigation.
  • Licorice and its active compounds possess known anti-inflammatory and antioxidant properties.

Purpose of the Study:

  • To evaluate the protective effects of licorice active compounds against MP-induced injury in rats.
  • To elucidate the underlying molecular mechanisms of licorice's protective action.
  • To identify specific protein targets involved in the therapeutic response.

Main Methods:

  • Establishment of a rat model with microplastic-induced colon and liver injury.
  • Treatment with a combination of liquiritigenin, isoliquiritigenin, and glycyrrhetinic acid.
  • Assessment of tissue damage, oxidative stress, inflammation, and tight junction proteins.
  • Label-free proteomics to identify differentially expressed proteins.

Main Results:

  • Licorice compounds significantly ameliorated colonic and liver damage induced by MPs.
  • Improved colonic barrier function and liver function were observed.
  • Reduced oxidative stress and systemic inflammatory factors were noted.
  • Fas-associating protein with a novel death domain (FADD) was identified as a key down-regulated protein interacting with licorice compounds.

Conclusions:

  • Licorice active compounds demonstrate significant protective efficacy against microplastic-induced tissue injury in rats.
  • The protective mechanism involves down-regulating FADD and direct interaction with the protein.
  • This study highlights licorice as a potential therapeutic agent for microplastic-related health issues.

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
353
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
328
Drugs Affecting GI Tract Motility: Other Laxatives01:20

Drugs Affecting GI Tract Motility: Other Laxatives

Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
497
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
317
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives01:22

Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives

Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
307